Renal Safety of Hydroxyethyl starch 130/0.42 After Cardiac Surgery: A Retrospective Cohort Analysis

被引:3
|
作者
Morath, Benedict [1 ,2 ,3 ]
Meid, Andreas D. [1 ]
Rickmann, Johannes [4 ]
Soethoff, Jasmin [5 ]
Verch, Markus [5 ]
Karck, Matthias [5 ]
Zaradzki, Marcin [5 ]
机构
[1] Heidelberg Univ Hosp, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany
[2] Heidelberg Univ, Cooperat Unit Clin Pharm, Heidelberg, Germany
[3] Heidelberg Univ Hosp, Hosp Pharm, Heidelberg, Germany
[4] Heidelberg Univ Hosp, Ctr Informat & Med Technol, Heidelberg, Germany
[5] Univ Hosp Heidelberg, Dept Cardiac Surg, Heidelberg, Germany
关键词
ACUTE KIDNEY INJURY; INFLAMMATORY RESPONSE SYNDROME; FLUID RESUSCITATION; SURGICAL-PATIENTS; SALINE; PATHOPHYSIOLOGY; CRYSTALLOIDS; MANAGEMENT; MORTALITY; COLLOIDS;
D O I
10.1007/s40264-021-01116-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction The risk for renal complications from hydroxyethyl starch 130/0.42 (HES) impacts treatment decisions in patients after cardiac surgery. Objective The objective of this study was to determine the impact of postoperatively administered HES on renal function and 90-day mortality compared to sole crystalloid administration in patients after elective cardiac surgery. Methods Using electronic health records from a university hospital, confounding-adjusted models analyzed the associations between postoperative HES administration and the occurrence of postoperative acute kidney injury. In addition, 90-day mortality was evaluated. The impact of HES dosage and timing on renal function on trajectories of estimated glomerular filtration rates over the postoperative period was investigated using linear mixed-effects models. Results Overall 1009 patients (45.0%) experienced acute kidney injury. Less acute kidney injury occurred in patients receiving HES compared with patients receiving only crystalloids for fluid resuscitation (43.7% vs 51.2%, p = 0.008). In multivariate acute kidney injury models, HES had a protective association (odds ratio: 0.89; 95% confidence interval 0.82-0.96). Crystalloids were not as protective as HES (odds ratio: 0.98; 95% confidence interval 0.95-1.00). There was no association between HES and 90-day mortality (odds ratio: 1.05; 95% confidence interval 0.88-1.25). Renal function trajectories were dose dependent and biphasic, HES appeared to slow down the late postoperative decline. Conclusions This study showed no association between HES and the postoperative occurrence of acute kidney injury and thus further closes the evidence gap on HES safety in cardiac surgery patients. Although this was a retrospective cohort study, the results indicated that HES might be safely administered to cardiac surgery patients with regard to renal outcomes, especially if it was administered early and dosed appropriately.
引用
收藏
页码:1311 / 1321
页数:11
相关论文
共 50 条
  • [41] Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.
    Amit Patel
    Umeer Waheed
    Stephen J. Brett
    Intensive Care Medicine, 2013, 39 : 1507 - 1508
  • [42] Renal injury after open versus laparoscopic non-cardiac surgery: a retrospective cohort analysis
    Essber, Hani
    Cohen, Barak
    Artis, Amanda S.
    Leung, Steve M.
    Maheshwari, Kamal
    Khan, Mohammad Zafeer
    Sessler, Daniel, I
    Turan, Alparslan
    Ruetzler, Kurt
    BRAZILIAN JOURNAL OF ANESTHESIOLOGY, 2021, 71 (01): : 50 - 57
  • [43] Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement is safe and effective in children
    R Suempelmann
    W Osthaus
    Critical Care, 12 (Suppl 2):
  • [44] Renal Injury After Open versus Laparoscopic Non-cardiac Surgery: A retrospective cohort analysis
    Kurt, Ruetzler
    Alparslan, Turan
    Eva, Rivas
    Daniel, Sessler
    SWISS MEDICAL WEEKLY, 2020, : 12S - 12S
  • [45] Hydroxyethyl Starch 6% 130/0.4 in a Balanced Electrolyte Solution and Renal Function After Nephrectomy
    Lee, Ho-Jin
    Kwon, Yongsuk
    Bae, Jinyoung
    Yoo, Seokha
    Yoon, Hee-Chul
    Yoon, Soo-Hyuk
    Kim, Jin-Tae
    Bahk, Jae-Hyon
    Kim, Won Ho
    ANESTHESIA AND ANALGESIA, 2020, 131 (04): : 1260 - 1269
  • [46] Etomidate and the Risk of Complications After Cardiac Surgery: A Retrospective Cohort Analysis
    Komatsu, Ryu
    Makarova, Natalya
    You, Jing
    Sessler, Daniel I.
    Anthony, David G.
    Kasuya, Yusuke
    Soltesz, Edward G.
    Turan, Alparslan
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2016, 30 (06) : 1516 - 1522
  • [47] EFFECT OF LOW DOSE 6% HYDROXYETHYL STARCH (130/0.4) AND RENAL FUNCTION IN CARDIAC SURGICAL PATIENTS
    Kanchi, Muralidhar
    Murali, Mohana
    Udresh, Manjunath
    Belani, Kumar G.
    ANESTHESIA AND ANALGESIA, 2019, 128 : 165 - 166
  • [48] Hydroxyethyl starch HES 130/0.4 in paediatric surgery: results of an explorative, controlled, multicentre safety study
    H Lochbühler
    Ch Galli
    H Hagemann
    Critical Care, 7 (Suppl 2):
  • [49] The Effect of Intraoperative 6% Balanced Hydroxyethyl Starch (130/0.4) During Cardiac Surgery on Transfusion Requirements
    Hans, Gregory A.
    Ledoux, Didiier
    Roediger, Laurence
    Hubert, Marie Bernard
    Koch, Jean-Noel
    Senard, Marc
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2015, 29 (02) : 328 - 332
  • [50] Hydroxyethyl starch 6% 130/0.42 in acetate-buffered Ringer's solution as a part of a balanced-volume resuscitation in abdominal surgery
    Kulla, M.
    Weidhase, R.
    Lampl, L.
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2008, 49 : 7 - +